RecruitingNot ApplicableNCT07579494

Explore the Impacts of Theta Burst Stimulation Over the Right Inferior Frontal Gyrus in Autism Spectrum Disorder: Combination of Clinical Symptoms, Neuropsychological Function and MRI

Sponsor

Chang Gung Memorial Hospital

Enrollment

60 participants

Start Date

May 5, 2026

Study Type

INTERVENTIONAL

Conditions

Autism Spectrum Disorder Theta Burst Stimulation Right Inferior Frontal Gyrus

Summary

Exploring the therapeutic efficacy of Theta Burst Stimulation (TBS) over the right inferior frontal gyrus (RIFG) in autism, including changes in core symptoms, adaptive functioning, neuropsychological performance, and neurophysiological signals.

Eligibility

Min Age: 8 YearsMax Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called intermittent theta burst stimulation for people with autism spectrum disorder, right inferior frontal gyrus, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 8 Years to 30 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.